China's Innovent Biologics May Look Into M&As, CFO Says

China's Innovent Biologics May Look Into M&As, CFO Says

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses a biopharmaceutical company's journey from its establishment in 2011 to becoming a major player in the industry. It highlights the company's achievements, including the development of a fully integrated platform and successful commercialization of biological products. The discussion covers market competition, particularly in China, and the company's strategies for global expansion through collaborations with international giants like Eli Lilly. Financial strategies, including a recent $610 million share placement, are also discussed, along with future plans for product development and market penetration.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What year was the company established?

2010

2013

2011

2012

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many products does the company currently have in development?

20

30

15

23

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which international giant is the company collaborating with?

Sanofi

Novartis

Eli Lilly

Pfizer

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main focus of the company's collaborations?

Research and Development

Marketing

Sales

Manufacturing

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the company's strategy to become a global biopharma player?

Increase local sales

Reduce product prices

Focus on domestic market

Collaborate with international companies

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How much money did the company raise for R&D and clinical trials?

$700 million

$800 million

$610 million

$500 million

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What are the company's plans for future development?

Stop collaborations

Reduce R&D efforts

Expand operations globally

Focus only on China